Distinct immunologic and radiographic patterns in etanercept-induced lung injury

Karina Serban, Michael Muzoora, Chadi Hage, Tim Lahm

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Nonspecific clinical presentation of non-infectious, immune-mediated pulmonary complications of etanercept therapy makes the diagnosis difficult. While bronchoalveolar lavage fluid (BALF) cell analysis is frequently used in diagnosing drug-induced lung disease, BALF patterns in etanercept-induced lung injury (EILI) are not well established. Furthermore, previous reports of EILI diagnosis relied on transbronchial or surgical lung biopsies. Here, we report two patients who developed pulmonary toxicity after etanercept treatment. Both patients were diagnosed with EILI. While one patient presented with CD4+-predominant lymphocytic alveolitis (consistent with a sarcoid-like pattern), the other patient exhibited a CD8+-predominant pattern (consistent with hypersensitivity pneumonitis-like reaction). The different BAL patterns were accompanied by distinct radiographic findings. Both patients significantly improved after etanercept discontinuation and corticosteroid initiation. We propose that EILI can present with distinct immunologic and radiographic phenotypes. In addition, early BALF analysis with lymphocyte immunophenotyping can further define the underlying immunologic abnormalities, and thereby, avoid more invasive procedures.

Original languageEnglish
Pages (from-to)18-20
Number of pages3
JournalRespiratory Medicine Case Reports
Volume8
Issue number1
DOIs
StatePublished - 2013

Fingerprint

Lung Injury
Bronchoalveolar Lavage Fluid
Lung
Extrinsic Allergic Alveolitis
Dimercaprol
Immunophenotyping
Etanercept
Lung Diseases
Adrenal Cortex Hormones
Phenotype
Biopsy
Therapeutics
Pharmaceutical Preparations

Keywords

  • Bronchoalveolar lavage
  • Hypersensitivity pneumonitis
  • Lymphocytic alveolitis
  • Sarcoid-like reaction
  • TNF-α antagonist

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Distinct immunologic and radiographic patterns in etanercept-induced lung injury. / Serban, Karina; Muzoora, Michael; Hage, Chadi; Lahm, Tim.

In: Respiratory Medicine Case Reports, Vol. 8, No. 1, 2013, p. 18-20.

Research output: Contribution to journalArticle

@article{0ea28e821f7b44d38ca90a1252bc62b1,
title = "Distinct immunologic and radiographic patterns in etanercept-induced lung injury",
abstract = "Nonspecific clinical presentation of non-infectious, immune-mediated pulmonary complications of etanercept therapy makes the diagnosis difficult. While bronchoalveolar lavage fluid (BALF) cell analysis is frequently used in diagnosing drug-induced lung disease, BALF patterns in etanercept-induced lung injury (EILI) are not well established. Furthermore, previous reports of EILI diagnosis relied on transbronchial or surgical lung biopsies. Here, we report two patients who developed pulmonary toxicity after etanercept treatment. Both patients were diagnosed with EILI. While one patient presented with CD4+-predominant lymphocytic alveolitis (consistent with a sarcoid-like pattern), the other patient exhibited a CD8+-predominant pattern (consistent with hypersensitivity pneumonitis-like reaction). The different BAL patterns were accompanied by distinct radiographic findings. Both patients significantly improved after etanercept discontinuation and corticosteroid initiation. We propose that EILI can present with distinct immunologic and radiographic phenotypes. In addition, early BALF analysis with lymphocyte immunophenotyping can further define the underlying immunologic abnormalities, and thereby, avoid more invasive procedures.",
keywords = "Bronchoalveolar lavage, Hypersensitivity pneumonitis, Lymphocytic alveolitis, Sarcoid-like reaction, TNF-α antagonist",
author = "Karina Serban and Michael Muzoora and Chadi Hage and Tim Lahm",
year = "2013",
doi = "10.1016/j.rmcr.2012.12.002",
language = "English",
volume = "8",
pages = "18--20",
journal = "Respiratory Medicine Case Reports",
issn = "2213-0071",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Distinct immunologic and radiographic patterns in etanercept-induced lung injury

AU - Serban, Karina

AU - Muzoora, Michael

AU - Hage, Chadi

AU - Lahm, Tim

PY - 2013

Y1 - 2013

N2 - Nonspecific clinical presentation of non-infectious, immune-mediated pulmonary complications of etanercept therapy makes the diagnosis difficult. While bronchoalveolar lavage fluid (BALF) cell analysis is frequently used in diagnosing drug-induced lung disease, BALF patterns in etanercept-induced lung injury (EILI) are not well established. Furthermore, previous reports of EILI diagnosis relied on transbronchial or surgical lung biopsies. Here, we report two patients who developed pulmonary toxicity after etanercept treatment. Both patients were diagnosed with EILI. While one patient presented with CD4+-predominant lymphocytic alveolitis (consistent with a sarcoid-like pattern), the other patient exhibited a CD8+-predominant pattern (consistent with hypersensitivity pneumonitis-like reaction). The different BAL patterns were accompanied by distinct radiographic findings. Both patients significantly improved after etanercept discontinuation and corticosteroid initiation. We propose that EILI can present with distinct immunologic and radiographic phenotypes. In addition, early BALF analysis with lymphocyte immunophenotyping can further define the underlying immunologic abnormalities, and thereby, avoid more invasive procedures.

AB - Nonspecific clinical presentation of non-infectious, immune-mediated pulmonary complications of etanercept therapy makes the diagnosis difficult. While bronchoalveolar lavage fluid (BALF) cell analysis is frequently used in diagnosing drug-induced lung disease, BALF patterns in etanercept-induced lung injury (EILI) are not well established. Furthermore, previous reports of EILI diagnosis relied on transbronchial or surgical lung biopsies. Here, we report two patients who developed pulmonary toxicity after etanercept treatment. Both patients were diagnosed with EILI. While one patient presented with CD4+-predominant lymphocytic alveolitis (consistent with a sarcoid-like pattern), the other patient exhibited a CD8+-predominant pattern (consistent with hypersensitivity pneumonitis-like reaction). The different BAL patterns were accompanied by distinct radiographic findings. Both patients significantly improved after etanercept discontinuation and corticosteroid initiation. We propose that EILI can present with distinct immunologic and radiographic phenotypes. In addition, early BALF analysis with lymphocyte immunophenotyping can further define the underlying immunologic abnormalities, and thereby, avoid more invasive procedures.

KW - Bronchoalveolar lavage

KW - Hypersensitivity pneumonitis

KW - Lymphocytic alveolitis

KW - Sarcoid-like reaction

KW - TNF-α antagonist

UR - http://www.scopus.com/inward/record.url?scp=84872387702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872387702&partnerID=8YFLogxK

U2 - 10.1016/j.rmcr.2012.12.002

DO - 10.1016/j.rmcr.2012.12.002

M3 - Article

AN - SCOPUS:84872387702

VL - 8

SP - 18

EP - 20

JO - Respiratory Medicine Case Reports

JF - Respiratory Medicine Case Reports

SN - 2213-0071

IS - 1

ER -